Results 121 to 130 of about 4,333 (186)

Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors

, 2017
Botulinum neurotoxin B is a Food and Drug Administration-approved therapeutic toxin. However, it has lower binding affinity toward the human version of its major receptor, synaptotagmin II (h-Syt II), compared to mouse Syt II, because of a residue ...
Krupp, Johannes, Feifan Yu, SunHyun Park, Lisheng Peng, Pierre-Etienne Chabrier, Park, SunHyun, Tao, Liang, Berntsson, Ronnie P. -A., Pål Stenmark, Johannes Krupp, Boone, Christopher, Min Dong, Stenmark, Pål,, Beard, Matthew, Berntsson, Ronnie P. -A.,, Matthew Beard, Peng, Lisheng, Yu, Feifan, Palan, Shilpa, Dong, Min, Liang Tao, Ronnie P.-A. Berntsson, Chabrier, Pierre-Etienne, Liu, Sai Man, Christopher Boone, Sai Man Liu, Stenmark, Pål, Shilpa Palan   +27 more
core   +1 more source

Characterization of a mosquitocidal botulinum toxin-like neurotoxin complex

reservedParaclostridial mosquitocidal protein 1 (PMP1), a botulinum-like toxin from Paraclostridium bifermentans, belongs to the clostridial neurotoxin (CNT) family, which includes botulinum and tetanus neurotoxins.
ANTONELLO, MARTA
core  

Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm

Clinical Ophthalmology, 2011
Juwan Park1, Michael S Lee2, Andrew R Harrison31Department of Ophthalmology, The Catholic University of Korea, Seoul, Korea; 2Department of Ophthalmology, Neurology and Neurosurgery, 3Department of Ophthalmology and Otolaryngology, University of ...
Park J, Lee MS, Harrison AR
doaj  

Clostridium botulinum neurotoxin [PDF]

Microbiological Reviews, 1980
openaire   +2 more sources

The Potential Therapeutic Effects of Botulinum Neurotoxins on Neoplastic Cells: A Comprehensive Review of In Vitro and In Vivo Studies

Toxins
A systematic review of the literature found fifteen articles on the effect of a botulinum toxin on neoplastic cell lines and eight articles on in vivo neoplasms.
Delaram Safarpour, Fattaneh A. Tavassoli, Bahman Jabbari   +2 more
doaj   +1 more source

In the human urothelium and suburothelium, intradetrusor botulinum neurotoxin type A does not induce apoptosis: preliminary results

, 2010
Intradetrusor injections of botulinum neurotoxin type A (BoNTA) are emerging as the preferred second-line treatment for neurogenic and idiopathic overactive bladder (OAB).
Khan, Shahid, Kessler, Thomas M, Fowler, Clare J, Brandner, Sebastian, Elneil, Sohier, Roosen, Alexander, Panicker, Jalesh N   +6 more
core   +1 more source

Immune response of horses to vaccination with the recombinant Hc domain of botulinum neurotoxin types C and D

, 2009
Botulinum neurotoxins, predominantly serotypes C and D, cause equine botulism through forage poisoning. The C-terminal part of the heavy chain of botulinum neurotoxin types C and D (HcBoNT/C and D) was expressed in Escherichia coli and evaluated as a ...
Stahl, C., Joachim Frey, Christina Stahl, Michel Popoff, Mazuet, C., Popoff, M., Unger, Lucia, Christelle Mazuet, Frey, J., Straub, R., Lucia Unger, Reto Straub   +11 more
core   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Intramuscular neural distribution of the soleus for botulinum neurotoxin injection: application to spasticity

Scientific Reports
Understanding the nerve distribution within the soleus muscle concerning anatomical landmarks is crucial for botulinum neurotoxin injections in managing spasticity.
Kyu-Ho Yi, Hyewon Hu, Sung-Oh Hwang, Ji-Hyun Lee, Hyung-Jin Lee   +4 more
doaj   +1 more source

Botulinum neurotoxin for head and neck disorders/ [edited by] Andrew Blitzer, Brian E. Benson, Diana N. Kirke

, 2020
Includes bibliographical references and index"Senior author Dr. Andrew Blitzer is an internationally renowned pioneer on the use of botulinum neurotoxin for functional disorders, with unparalleled expertise on this topic.
Benson Brian E., Kirke Diana N., Blitzer Andrew   +2 more
core